Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report

By sjmartinez • May 17, 2024

Steiger A, VanderVeen NT, Kang EH, Weimer AK. Resolution of metabolic dysfunction-associated steatohepatitis with estradiol in a transgender female: A case report. JPGN Rep. 2024 Feb 26;5(2):223-227. doi: 10.1002/jpr3.12054. PMID: 38756118; PMCID: PMC11093893.

Tags: chief residents, GAHT, gender‐affirming hormone therapy, General Internal Medicine, MASLD, Med Peds, metabolic dysfunction‐associated steatotic liver disease, NAFLD, NASH, Nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, Publications, Resident, residents, TGD, transgender and gender‐diverse youth

Alcohol-Associated Hepatitis: Short- and Long-Term Management

De La Torre SA Jr, Morcos M, Saab S, Shetty A. Alcohol-Associated Hepatitis: Short- and Long-Term Management. Dig Dis Sci. 2024 Nov 22. doi: 10.1007/s10620-024-08705-1.[...]

Population health strategies for health equity in chronic kidney disease management

Brown CO, Pham PC, Shah A, Dukkipati R, Shen J, Dai T, Raff EA, Kalantar-Zadeh K. Population health strategies for health equity in chronic kidney[...]

The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective study

Gutiérrez-Peredo GB, Montaño-Castellón I, Gutiérrez-Peredo AJ, Lopes MB, Tapioca FPM, Guimaraes MGM, Montaño-Castellón S, Guedes SA, da Costa FPM, Mattoso RJC, Filho JCBO, Norris KC,[...]